Systematic reviewindependent cross-checkabstract only checked I-CAN-07 standard review

High sugar intake is linked to many health problems, weakly to some cancers

Dietary sugar consumption and health: umbrella review.

Overview

Huang Y et al.. BMJ 2023 · PMID 37019448 · DOI 10.1136/bmj-2022-071609

Evidence for weight gain is moderate; links with cancers are mostly low quality.

Does the study support the specific claim? Unclear · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Review sugar-health evidence.

How was the study done?

Umbrella review.

How many people, animals or samples were studied?

73 meta-analyses.

What was actually found?

Mostly harmful associations.

How large was the observed effect?

Fructose +22% pancreatic cancer per 25 g/d (low quality).

What do the results mean in everyday life?

Limit added sugar.

What are the study's limitations?

Observational.

What does it say about Elawady's specific claim?

Does not show sugar 'feeds' tumours.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Effects in cancer patients.

Scientific in-depth review

1. Full reference

Authors
Huang Y et al.
Journal
BMJ
Year
2023
Identifier
PMID 37019448 DOI 10.1136/bmj-2022-071609
Verification
verified – PubMed esummary + efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

National Natural Science Foundation of China; Sichuan province programme

2. Research question

Associations of dietary sugar with health outcomes.

3. Study design and population

Study design
Systematic review – Umbrella review of meta-analyses
Population

Humans free of disease at baseline

Country

International

Period

Literature to search date

Sample size

73 meta-analyses; 83 outcomes

Inclusion and exclusion criteria

Meta-analyses of RCTs or observational studies

4. Methods and endpoints

Exposure / intervention

Dietary sugar

Comparator

Lower intake

Endpoints

83 health outcomes

Statistical methods

Evidence grading

5. Actual results

Results

Harmful associations with 18 endocrine/metabolic, 10 cardiovascular, 7 cancer and 10 other outcomes. Moderate quality: SSB and body weight; added sugar and ectopic fat. Low quality: each 25 g/day fructose with 22% higher pancreatic cancer risk.

Absolute risks

not reported

Authors' conclusion

High sugar intake is generally more harmful than beneficial; limit free sugars to <25 g/day.

6. Strengths

  • Comprehensive

7. Weaknesses

  • Mostly observational, low-quality evidence for cancer outcomes

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Umbrella review; quality of underlying evidence often low.

9. Assessment of the statistical interpretation

Cancer associations are low quality; strongest evidence for weight/cardiometabolic outcomes.

10. Relevance to the specific claim

Context for sugar and cancer: weak direct cancer evidence; indirect via body weight.

11. Independent contrary findings

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Context; see sugar_soda team.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessindirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Effect of sugar intake in patients with existing cancer.

15. Linked fact checks